These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 28106046)
1. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro. Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046 [TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models. Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Oncotarget; 2016 Dec; 7(51):85273-85282. PubMed ID: 27863373 [TBL] [Abstract][Full Text] [Related]
3. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models. Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models. Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Fujiwara T; Bouvet M; Hoffman RM Anticancer Res; 2017 Jan; 37(1):57-60. PubMed ID: 28011473 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Metastatic Recurrence Via Lymphatic Trafficking of a High-Metastatic Variant of Human Triple-Negative Breast Cancer After Surgical Resection in Orthotopic Nude Mouse Models. Yano S; Takehara K; Tazawa H; Kishimoto H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM J Cell Biochem; 2017 Mar; 118(3):559-569. PubMed ID: 27626220 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation. Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Anticancer Res; 2016 Aug; 36(8):3817-20. PubMed ID: 27466482 [TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence. Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Oncotarget; 2016 Nov; 7(46):75635-75647. PubMed ID: 27689331 [TBL] [Abstract][Full Text] [Related]
8. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus. Sasaki T; Tazawa H; Hasei J; Osaki S; Kunisada T; Yoshida A; Hashimoto Y; Yano S; Yoshida R; Kagawa S; Uno F; Urata Y; Ozaki T; Fujiwara T Gene Ther; 2013 Jan; 20(1):112-8. PubMed ID: 22241176 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494 [TBL] [Abstract][Full Text] [Related]
10. Telomerase-specific virotheranostics for human head and neck cancer. Kurihara Y; Watanabe Y; Onimatsu H; Kojima T; Shirota T; Hatori M; Liu D; Kyo S; Mizuguchi H; Urata Y; Shintani S; Fujiwara T Clin Cancer Res; 2009 Apr; 15(7):2335-43. PubMed ID: 19318473 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents. Fujiwara T; Urata Y; Tanaka N Front Biosci; 2008 Jan; 13():1881-6. PubMed ID: 17981675 [TBL] [Abstract][Full Text] [Related]
12. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene. Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413 [TBL] [Abstract][Full Text] [Related]
13. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827 [TBL] [Abstract][Full Text] [Related]
14. [Theranostic application of telomerase-specific oncolytic adenovirus for human cancer]. Fujiwara T; Tanaka N Nihon Rinsho; 2007 Oct; 65(10):1913-22. PubMed ID: 17926546 [TBL] [Abstract][Full Text] [Related]
15. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Kishimoto H; Urata Y; Tanaka N; Fujiwara T; Hoffman RM Mol Cancer Ther; 2009 Nov; 8(11):3001-8. PubMed ID: 19887549 [TBL] [Abstract][Full Text] [Related]
16. FGF13 promotes metastasis of triple-negative breast cancer. Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer. Zhu W; Zhang H; Shi Y; Song M; Zhu B; Wei L Cancer Biol Ther; 2013 Nov; 14(11):1016-23. PubMed ID: 24025362 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines. Sato D; Kurihara Y; Kondo S; Shirota T; Urata Y; Fujiwara T; Shintani S Oncol Rep; 2013 Dec; 30(6):2659-64. PubMed ID: 24065118 [TBL] [Abstract][Full Text] [Related]
19. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer. Kikuchi S; Kishimoto H; Tazawa H; Hashimoto Y; Kuroda S; Nishizaki M; Nagasaka T; Shirakawa Y; Kagawa S; Urata Y; Hoffman RM; Fujiwara T Mol Ther; 2015 Mar; 23(3):501-9. PubMed ID: 25523761 [TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Kishimoto H; Kojima T; Watanabe Y; Kagawa S; Fujiwara T; Uno F; Teraishi F; Kyo S; Mizuguchi H; Hashimoto Y; Urata Y; Tanaka N; Fujiwara T Nat Med; 2006 Oct; 12(10):1213-9. PubMed ID: 17013385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]